Search
CONGRESS 2023 - The new electronic Registration Training Portfolio - a get ready guide for trainees and trainers
28/09/2023
The transition to a digital-only Registration Training Portfolio using the ePortfolio platform Onefile, will redefine students, apprentices and laboratory-based staff complete this integral part of their journey to HCPC registration as biomedical scientists and represents an up-to-date approach to education and training.
This talk (the second of three) will demonstrate how Onefile can be used by trainees and trainers to provide an enhanced training experience over traditional paper-based portfolios. We will delve into the use of Onefile to create and upload evidence; set tasks and monitor deadlines; organise meetings and track progress against the HCPC Standards of Proficiency; identify training gaps and create workflows to sign-off each module in the portfolio. We will see how Onefile provides a comprehensive audit trail with minimal user input and how this can be used to help ensure quality education and training in the workplace.
We suggest that this talk will be informative to trainees undertaking version 5.0 of the Registration Training Portfolio, as well as delegates in roles that support trainees, such as training officers/managers and university placement tutors.
Additional talks focusing on other elements of Onefile are scheduled for the lunchtime programme on Wednesday (Hall: 11) and the afternoon subsidiary programme on Thursday (Hall: 4).
This talk (the second of three) will demonstrate how Onefile can be used by trainees and trainers to provide an enhanced training experience over traditional paper-based portfolios. We will delve into the use of Onefile to create and upload evidence; set tasks and monitor deadlines; organise meetings and track progress against the HCPC Standards of Proficiency; identify training gaps and create workflows to sign-off each module in the portfolio. We will see how Onefile provides a comprehensive audit trail with minimal user input and how this can be used to help ensure quality education and training in the workplace.
We suggest that this talk will be informative to trainees undertaking version 5.0 of the Registration Training Portfolio, as well as delegates in roles that support trainees, such as training officers/managers and university placement tutors.
Additional talks focusing on other elements of Onefile are scheduled for the lunchtime programme on Wednesday (Hall: 11) and the afternoon subsidiary programme on Thursday (Hall: 4).
CONGRESS 2023 - The new HCPC standards of proficiency, the new electronic Registration Training Portfolio – explaining both
28/09/2023
This presentation will provide a detailed review of the updated HCPC Standards of Proficiency (SoPs) for biomedical scientists. The standards were updated in 2022 and have been implemented from 1st September 2023.
The updated SoPs for biomedical scientists align to the contents of the IBMS Registration Training Portfolio which must be successfully completed to register as a biomedical scientist. The updated Registration Training Portfolio (Version 5.0) has been mapped to the updated HCPC SoPs and will be issued to all applicants after 1st September 2023.
Both colleagues undertaking training to become registered biomedical scientists and those who are already registrants with the HCPC will be required to meet the new HCPC SoPs.
The language in the updated SoPs is much more focussed on demonstrating the standards rather than having knowledge of them, which will require a shift in how we evidence that the standards are met in practice.
This session will discuss the Version 5.0 portfolio structure, examples of evidence types that can be used to demonstrate the updated standards and will also introduce the mandatory pieces of evidence that are now part of each module of the Version 5.0 IBMS Registration Training Portfolio. The rationale for the changes to the portfolio and the support available from the Institute during this transition period will also be explained.
This talk will be informative for anyone who is involved in or responsible for pre-registration laboratory training, in particular registration training portfolio candidates, training officers, laboratory managers and university placement tutors.
Several sessions will be presented by the IBMS Head of Digital Education (Jim Taylor) throughout Congress, explaining how the Version 5.0 digital portfolio on Onefile will provide and enhanced training experience over traditional paper-based portfolios.
The updated SoPs for biomedical scientists align to the contents of the IBMS Registration Training Portfolio which must be successfully completed to register as a biomedical scientist. The updated Registration Training Portfolio (Version 5.0) has been mapped to the updated HCPC SoPs and will be issued to all applicants after 1st September 2023.
Both colleagues undertaking training to become registered biomedical scientists and those who are already registrants with the HCPC will be required to meet the new HCPC SoPs.
The language in the updated SoPs is much more focussed on demonstrating the standards rather than having knowledge of them, which will require a shift in how we evidence that the standards are met in practice.
This session will discuss the Version 5.0 portfolio structure, examples of evidence types that can be used to demonstrate the updated standards and will also introduce the mandatory pieces of evidence that are now part of each module of the Version 5.0 IBMS Registration Training Portfolio. The rationale for the changes to the portfolio and the support available from the Institute during this transition period will also be explained.
This talk will be informative for anyone who is involved in or responsible for pre-registration laboratory training, in particular registration training portfolio candidates, training officers, laboratory managers and university placement tutors.
Several sessions will be presented by the IBMS Head of Digital Education (Jim Taylor) throughout Congress, explaining how the Version 5.0 digital portfolio on Onefile will provide and enhanced training experience over traditional paper-based portfolios.
CONGRESS 2023 - The new molecular pathology Specialist Portfolio
27/09/2023
The new molecular pathology Specialist Portfolio
CONGRESS 2023 - Thrombophilia Guideline Update
27/09/2023
Thrombophilia is defined as hereditary and/or acquired conditions associated with an increased predisposition to thrombosis. The previous British Society for Haematology guideline on thrombophilia testing (2012) focused only heritable thrombophilia testing. The updated guideline published in 2022 (1) has a widened scope to include both heritable and acquired thrombophilia especially antiphospholipid antibodies, paroxysmal nocturnal haemoglobinuria, myeloproliferative neoplasm (MPN) and the presence of a JAK2 mutation in the absence of an MPN phenotype. Disorders such as cancer, inflammatory conditions and obesity are associated with thrombosis through multiple mechanisms, but these are not included in the guideline which focuses only the factors identified from laboratory testing.
The key principle in the guideline is that when clinical utility of testing is not clear, thrombophilia testing is not mandatory, and testing should be done only if the result will alter the management of the patient. These guidelines emphasise the importance of identifying antiphospholipid syndrome and JAK2 +/- MPN phenotype because they have a significant impact on management. The guidelines confirm the limited utility of testing for hereditary thrombophilia testing in venous thromboembolism, arterial thrombosis and recurrent pregnancy loss.
1. Arachchillage, DJ, Mackillop, L, Chandratheva, A, Motawani, J, MacCallum, P, Laffan, M. Thrombophilia testing: A British Society for Haematology guideline. Br J Haematol. 2022; 198: 443– 458. https://doi.org/10.1111/bjh.18239
The key principle in the guideline is that when clinical utility of testing is not clear, thrombophilia testing is not mandatory, and testing should be done only if the result will alter the management of the patient. These guidelines emphasise the importance of identifying antiphospholipid syndrome and JAK2 +/- MPN phenotype because they have a significant impact on management. The guidelines confirm the limited utility of testing for hereditary thrombophilia testing in venous thromboembolism, arterial thrombosis and recurrent pregnancy loss.
1. Arachchillage, DJ, Mackillop, L, Chandratheva, A, Motawani, J, MacCallum, P, Laffan, M. Thrombophilia testing: A British Society for Haematology guideline. Br J Haematol. 2022; 198: 443– 458. https://doi.org/10.1111/bjh.18239
CONGRESS 2023 - Transforming your pathology workforce
27/09/2023
Join your network workforce leads/practice educators for a solution focused discussion around workforce challenges. Find out about current education and development opportunities with specific emphasis on support workers, advanced clinical practice and leadership. We welcome your participation in helping to shape the future of your pathology workforce.
You are invited by the speakers to complete this online form before the presentation
You are invited by the speakers to complete this online form before the presentation
CONGRESS 2023 - Transforming your pathology workforce (Wednesday)
27/09/2023
Join your network workforce leads/practice educators for a solution focused discussion around workforce challenges. Find out about current education and development opportunities with specific emphasis on support workers, advanced clinical practice and leadership. We welcome your participation in helping to shape the future of your pathology workforce.
You are invited by the speakers to complete this online form before the presentation
You are invited by the speakers to complete this online form before the presentation
CONGRESS 2023 - Transplant Assessment and Relative Opportunity Tool (TAROT) for Renal Transplantation: Improving the chance of transplant for immunologically complex patients
26/09/2023
Transplant Assessment and Relative Opportunity Tool (TAROT) for Renal Transplantation: Improving the chance of transplant for immunologically complex patients
CONGRESS 2023 - Vaccines and immunodeficiency testing (Wednesday)
27/09/2023
A person's immune response to previous antigen exposure is one of the most useful measures of how well their immune system is functioning. Vaccination provides a controlled and standardised exposure to an antigen, with the ability to assess immune responses prior to and after exposure. Different vaccine types can be used to explore different aspects of immune function.
Traditionally, antibody levels have been used to interrogate these responses, and it is possible to explore the quality of the antibody response and also cellular responses. A wide variability in the response to vaccination in healthy individuals can complicate interpretation of vaccine responses in patients with recurrent infections. Protection from infection is multifactorial, and while our ability to assess vaccine responses is improving, this alone is often not enough to assess an individual's immunity.
Traditionally, antibody levels have been used to interrogate these responses, and it is possible to explore the quality of the antibody response and also cellular responses. A wide variability in the response to vaccination in healthy individuals can complicate interpretation of vaccine responses in patients with recurrent infections. Protection from infection is multifactorial, and while our ability to assess vaccine responses is improving, this alone is often not enough to assess an individual's immunity.